Forty-three patients were included. Compared to baseline, after CRT through p-HBP, there were immediate significant changes in the
QT interval (ms): 445 [407.5–480] vs 410 [385–440] (
p = 0.006),
QT dispersion (ms): 80 [60–100] vs 40 [40–65] (
p < 0.001),
Tp-
Te (ms): 90 [80–110] vs 80 [60–95] (
p < 0.001),
Tp-
Te/
QT ratio: 0.22 [0.19–0.23] vs 0.19 [0.16–0.21] (
p < 0.001),
T wave amplitude (mm): 6.25 [4.88–10] vs − 2.5 [− 7–2.25] (
p < 0.001), and
T wave duration (ms): 190 [157.5–200] vs 140 [120–160] (
p = 0.001). In the cases of the corrected
QT (Bazzett and Friederichia) and the
Tp-
Te dispersion, changes only became significant at 1 month post-implant (468.5 [428.8–501.5] vs 440 [410–475.25] (
p = 0.015); 462.5 [420.8–488.8] vs 440 [400–452.5] (
p = 0.004), and 40 [30–52.5] vs 30 [20–40] (
p < 0.001), respectively) (Table
1). Finally, two parameters did not improve until 6 months post-implant: the
rdT/
JT index, 0.25 [0.21–0.28] baseline vs 0.20 [0.19–0.23] 6 months post-implant (
p = 0.011), and the
JT interval, 300 [240–340] baseline vs 280 [257–302] 6 months post-implant (
p = 0.027). Additionally, most of the parameters continued improving as compared with immediate post-implantation.